Bronchiectasis Medical Slides
Generate publication-quality bronchiectasis lecture slides in 30 seconds. AI-powered content structured for clinical education.
Generate Bronchiectasis DeckWhy teach Bronchiectasis?
Bronchiectasis prevalence has increased by 40% over the past decade, affecting approximately 350-566 per 100,000 adults. Post-infectious causes remain most common globally, though idiopathic bronchiectasis accounts for 30-50% of cases in developed countries. The 2017 ERS guidelines provide the framework for etiological workup, and the Bronchiectasis Severity Index (BSI) guides risk stratification and management intensity.
What AI generates for Bronchiectasis
Enter “Bronchiectasis” and SlideCraft generates a complete lecture deck with slides like these.
Mira en accion
Escribe cualquier tema medico y observa como la IA genera una diapositiva de presentacion en segundos. Sin necesidad de registro.
3 vistas previas gratuitas por hora · Sin necesidad de cuenta
Ingresa un tema y haz clic en Generar para ver tu diapositiva con IA
Bronchiectasis Presentation FAQ
What etiological workup should be presented in bronchiectasis teaching?
Present the ERS 2017 minimum workup: immunoglobulins (IgG, IgA, IgM — immunodeficiency in 2-8%), specific antibody responses, ABPA screen (total IgE, Aspergillus-specific IgE/IgG — ABPA in 1-10%), sputum culture (including mycobacteria), and consider: CF testing (sweat chloride + CFTR genetics, especially if age <40), alpha-1 antitrypsin level, ciliary function testing, autoimmune panel. Up to 30-50% remain idiopathic despite comprehensive evaluation.
How should long-term macrolide evidence be presented?
Present the three landmark trials: EMBRACE (azithromycin 500 mg 3x/week reduced exacerbations, NZ), BAT (azithromycin 250 mg daily reduced exacerbations by 70%, Netherlands), BLESS (erythromycin 400 mg twice daily reduced exacerbations, Australia). Common findings: approximately 50% reduction in exacerbation frequency. Key considerations: screen for NTM before starting (risk of macrolide resistance), ECG for QTc prolongation, hearing assessment, liver function monitoring. ERS recommends for ≥3 exacerbations/year.
What Pseudomonas management strategy should be covered?
Present the significance: Pseudomonas colonization is associated with 3-fold increased mortality and accelerated lung function decline. Eradication protocol at first isolation: IV anti-pseudomonal antibiotics or inhaled colistin/tobramycin for 2-4 weeks. Chronic Pseudomonas: long-term inhaled antibiotics (nebulized colistin, tobramycin, or aztreonam in 28-day on/off cycles). Reference RESPIRE 1 and 2 trials for inhaled ciprofloxacin dry powder. BSI scoring guides treatment intensity.
Precios simples, sin sorpresas
Empieza gratis hoy. Suscribete cuando tu departamento necesite mas.
Gratuito
Prueba SlideCraft sin compromiso
- 2 presentaciones por mes
- Diapositivas con IA + notas del presentador
- Ver y presentar (sin exportar)
- Almacenamiento en la nube por 7 dias
- Slide Checker & Outline Generator
Pro
Para clinicos que dan clase cada semana
- 10 presentaciones/mes + $2.50/extra
- Modo Critico con IA (analisis 5 ejes)
- Documento a presentacion (PDF)
- Exportar PDF, PPTX, SCORM e imagen
- Almacenamiento permanente en la nube
Expert
Para medicos academicos que publican y presentan
- 25 presentaciones/mes + $2.00/extra
- Verificacion de fuentes PubMed
- Pipeline articulo-a-presentacion
- Citas automaticas (Vancouver)
- Todo del plan Pro